Transitioning a Pain Program Away From Chronic Opioid Prescribing.

Slides:



Advertisements
Similar presentations
TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
Advertisements

Aug 7 09 Co-Occurring Service Array Psychiatric Evaluation Comprehensive Evaluation Medication Monitoring Medications Clinical Consultation Family Therapy.
Co-Occurring Service Array Psychiatric Evaluation Medication Monitoring Clinical Consultation Family Therapy Individual Therapy / Individual Therapy-Crisis.
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Individual Treatment Plan Putting Together the Pieces of the Puzzle Gayla Oakley RN, FAACVPR Boone County Health Center Albion Nebraska Presented by Mark.
Role of the Pharmacist in Collaborative Care for Mental Health and Addiction Treatment in Medically Underserved Appalachia Sarah T. Melton, PharmD,BCPP,CGP.
Integration of Mental Health, Substance Abuse, and Primary Care Presented by Dianne Sceranka, RN Veronica Camacho, LCSW And Daniel Peters, Alcohol and.
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Swinomish Wellness Program
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Behavioral Health Services for Injured or Ill workers – Collaborative Care Analysis and Recommendations January 22, 2015.
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
JANUARY 2013 SUBSTANCE ABUSE TREATMENTBASICS. WHY DO PEOPLE USE DRUGS AND ALCOHOL? People use substances such as alcohol and other drugs because they.
Psychiatric Mental Health Nursing in Acute Care Settings.
Rehabilitation Programs and Office Follow-up Steven R. Ey, M.D. Medical Director Genesis Chemical Dependency Unit South Coast Medical Center Laguna Beach,
Psychiatric Services in an Emergency Department Prepared by: Kathleen Crapanzano, MD DHH, OMH Medical Director Presented by: Patricia Gonzales, LCSW Acting.
® Introduction Substance Abuse and Use of Opioids for Low Back Pain Nabil Aounallah, Sunand Kallumadanda, MD, Sandra Burge, PhD The University of Texas.
Behavioral Health Issues and Pediatric Hospitalizations Stephen R. Gillaspy, PhD 11/05/09 Reaching Out To Oklahoma III Annual Pediatric Interdisciplinary.
Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective Marek C. Chawarski Yale University School of Medicine.
Role of Health Care Providers or Sports Medicine Team Members.
Slide 1 of xx Emerging Pharmacy Issues in the Texas Workers’ Compensation System Presented by Suzanne Novak, MD, PhD CEO, Austin Outcomes Research, Inc.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
Geriatric Psychiatry Services JoAnn Pelletier-Bressette, RN, Nurse Manager Nancy Hooper, BScN, RN, CPMHN (C) 1.
Sophie Lanzkron, MD, MHS Associate Professor of Medicine and Oncology Johns Hopkins School of Medicine.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
Illness Behavior Assistant Professor Dr. Ali K. Al-mesrawi Ph.D Mental Health Nursing
Care Planning: Better health begins here... April 2013.
Josette Dorius, Service Director Autism Council of Utah April 6, 2011.
Procedural Interventions And Chronic Low Back Pain: Changes Over One Year This sample included 137 patients with complete surveys and chart reviews; 74%
Introduction: Medical Psychology and Border Areas
Placebo-Controls in Short-Term Clinical Trials of Hypertension Sana Al-Khatib, MD, MHS Assistant Professor of Medicine Division of Cardiology Duke University.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
What Does Research Tell Us? Care Manager Roles in Depression Care.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
Addiction and dependence Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Readmissions Driver Diagram OHA HEN 2.0. Readmissions AIMPrimary Drivers Secondary DriversChange Ideas Reduce Readmissions Identify patients at high-risk.
CDC Guideline for Prescribing Opioids for Chronic Pain Presenter’s Name Presenter’s Title Title of Event Date of Event Centers for Disease Control and.
Vista Resources: Opiate Oversight Committee (OOC) Submit cases to your peers for support and guidance around complex issues Finding Wellness Amidst Chronic.
Stanford Chronic Disease Self-Management Program.
Mosby items and derived items © 2009, 2005 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 43 Pain Management.
Foundations of Addictions Counseling, 3/E David Capuzzi & Mark D. Stauffer Copyright © 2016, 2012, 2008 by Pearson Education, Inc. All Rights Reserved.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
Current Concepts in Pain Management
St Anne’s Alcohol Services Dual Diagnosis Practice Development Event
Wireless Access SSID: cwag2017
Section IV: Principles of Pain Management
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
Medication-Assisted Therapy at Coleman Profession Services
Neonatal Abstinence Syndrome (NAS) Program Overview
STOP! Safe Treatment of Pain
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Opioid Prescribing & Monitoring
Treatments for Addiction
Treating Alcohol Abuse
Opioids in Butte County
Assessing Opioid Use Disorder, part 1
collaboration giving community 2018 HOUSTON OPIOID SUMMIT
Essentials of Good Pain Care: A Team-Based Approach
The Judicial Branch’s Response to the Opioid Crisis
Medication Assisted Treatment of Opioid Use Disorder
Tapering and Discontinuing Chronic Opioid Therapy
Can be personalized to individual group needs.
Presentation transcript:

Transitioning a Pain Program Away From Chronic Opioid Prescribing

Steve (Stephen Z. Hull, M.D.)

Transitioning a Pain Program Away From Chronic Opioid Prescribing

30% of patients prescribed opioids chronically become addicted % demonstrating observed signs of addiction (Fishbain DA, et.al. Pain Medicine 2008;9(4):444–459.)

January 4, 2011 Maine plagued by painkiller habit A growing epidemic of abuse is behind an addiction treatment rate that is eight times the national average. By John Richardson State House BureauJohn Richardson

26% for purposeful oversedation 39% for increasing dose without prescription 8% for obtaining extra opioids from other doctors 18% for use for purposes other than pain 20% for drinking alcohol to relieve pain 12% for hoarding pain medications Michael Von Korff, ScD, Annals of Internal Medicine, 6 September 2011

Perspective A Flood of Opioids a Rising Tide of Deaths Susan Okie, M.D. N Engl J Med 2010; 363: November 18, 2010November 18, 2010

National Center for Injury Prevention and Control

Chief Judge John A. Woodcock, Jr. – U.S. District Court, District of Maine Federal Criminal Law

No end organ toxicity No ceiling dose Safer and more effective than OTCs Addiction Respiratory depression and overdose death Endocrinologic dysfunction Immune dysfunction Opioid induced hyperalgesia

There is no evidence from randomized controlled trials to support the popular assertion that the benefits of long term opioid therapy outweigh the risks. Major Study Limitations Used placebo comparators Invariably excluded patients at high risk of serious adverse events Trials that have been completed were generally short term (<16 weeks)

There is no evidence from randomized controlled trials to support the popular assertion that the benefits of long term opioid therapy outweigh the risks. The findings of this systematic review suggest that proper management of a type of strong painkiller (opioids) in well-selected patients with no history of substance addiction or abuse can lead to long-term pain relief for some patients.

Ten-year follow-up of chronic non-malignant pain patients: Opioid use, health related quality of life and health care utilization Opioid Users had: Higher pain levels Poorer self-rated health Higher unemployment Greater use of the healthcare system More maladaptive coping skills Lower health-related quality of life (SF-36)

Ten-year follow-up of chronic non-malignant pain patients: Opioid use, health related quality of life and health care utilization Study Limitations Denmark has the highest use of opioids in the world Cross-sectional epidemiological research, cannot be established a causal relationships

Ten-year follow-up of chronic non-malignant pain patients: Opioid use, health related quality of life and health care utilization “It is remarkable that opioid treatment of long- term/chronic noncancer pain does not seem to fulfill any of the key outcome opioid treatment goals…"

Ten-year follow-up of chronic non-malignant pain patients: Opioid use, health related quality of life and health care utilization “It is remarkable that opioid treatment of long- term/chronic noncancer pain does not seem to fulfill any of the key outcome opioid treatment goals: pain relief, improved quality of life, and improved functional capacity."

A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission At admission patients using opioids reported significantly greater pain severity and depression. Significant improvement was found on all outcome variables following treatment and six-month posttreatment regardless of opioid status at admission.

Outcome Variable Non Showing Differences Depression Pain catastrophizing Pain interference Perceived control over pain/life General activity Health perception Physical functioning Social functioning Role limitations related to physical problems Role limitations from emotional factors

A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission At discharge, patients taking higher doses continued to report significantly greater pain severity than the non- opioid group. Patients in the opioid cohort who completed rehabilitation and opioid withdrawal maintained treatment gains comparable to those in the non-opioid cohort.

A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission Study Limitations Self-selection bias Methodology of this study precluding causal inferences suggesting patients’ functioning improved because of the opioid withdrawal

Chronic Noncancer Pain Rehabilitation With Opioid Withdrawal: Comparison of Treatment Outcomes Based on Opioid Use Status at Admission No significant pretreatment differences were found between the opioid and nonopioid group regarding demographics, pain duration, treatment completion. No significant differences were found regarding all outcome variables, including pain severity, between the opioid and nonopioid group.

Multidisciplinary rehabilitation for chronic low back pain: systematic review Twelve randomized comparisons of multidisciplinary treatment and a control condition. Strong evidence that intensive multidisciplinary biopsychosocial rehabilitation with functional restoration improves function when compared with inpatient or outpatient non-multidisciplinary treatments. Moderate evidence that intensive multidisciplinary biopsychosocial rehabilitation with functional restoration reduces pain.

History Interventional Pain Management and Medical Pain Management

1.Confirm diagnosis 2.Exhaust interventional options 3.Functional rehabilitation a.Physical therapy/exercise b.Cognitive behavioral therapy c.Adaptive equipment d.Lifestyle change e.Medication management

Evolution Interdisciplinary Biopsychosocial Rehabilitation and Medically Managed Opioid Withdrawal

1.Patient selection evaluations a.Physiatry/pain medicine evaluation b.Psychiatry/psychology evaluation c.Addiction medicine evaluation

1.Patient selection evaluations 2.Treatment program a.2 ½ hour treatment days I.1 hour of cognitive behavioral therapy (Health and Behavior codes) II.¼ hour mindfulness exercise III.1 hour of physical exercise (Group Medical Visit coding) IV.¼ hour homework assignment

1.Patient selection evaluations 2.Treatment program a.2 ½ hour treatment days b.12 week program I.Orientation/foundational training week II.Treatment weeks i.5-week opioid taper ii.5-week opioid free III.Discharge planning week c.Open ended aftercare program

Treatment Team: 1.Patient 2.Family 3.Physiatrist/pain physician 4.Psychiatrist 5.Psychologist 6.Addiction medicine provider 7.Nurse Practitioner 8.Registered nurse 9.Physical therapy assistant/exercise instructor 10.Medical assistant 11.Support staff

Medically Managed Opioid Withdrawal Pretreatment detox Supported progressive taper (5-weeks) Adjuvant medication management Suboxone induction and rapid taper Suboxone induction and maintenance

MJ Christie, Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. British Journal of Pharmacology (2008) 154, 384–396

Thanks